S-propargyl-cysteine promotes the stability of atherosclerotic plaque via maintaining vascular muscle contractile phenotype

S-propargyl-cysteine promotes the stability of atherosclerotic plaque via maintaining vascular muscle contractile phenotype

Introduction: Plaque rupture in atherosclerosis contributes to various acute cardiovascular events. As a new sulfide-containing donor, S-propargyl-cysteine (SPRC) has been reported to play a beneficial role in cardioprotection, potentially through its anti-inflammatory, anti-oxidative and anti-ather...

Full description

Bibliographic Details
Main Authors: Li Ping, Li Zhi-Ming, Zhang Bi-Shan, Zhu Lei, Yu Bo, Zhu Yi-Chun, Wang Ming-Jie
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
atherosclerosis
S-propargyl-cysteine
plaque stabilization
VSMCs
phenotype switching
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1291170/full

Similar Items

Similar Items